AGEING RESEARCH REVIEWS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-12-27 ms3000000013472483 来自广东省

submitted to journal 5天，正常吗？

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-10-29 傲娇的小马尾

审稿速度:3.0 | 投稿命中率:50.0
经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下

126 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-01-02 NAOHOO

with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表:
今天终于接收了，mark

imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark

107 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-07-11 ms6000002054670522

with aditor一般要多久呀

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-04-25 Michael scofield123

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：衰老
经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍

45 0

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-02-03 120b32b6m98(暂无昵称)

想问一下大家，投这个杂志要钱吗

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-01-30 ms8406716658181247

2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-05-21 da-xiang

审稿速度:3.0 | 投稿命中率:25.0
经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利
兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下
http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413

83 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-28 MS68862005

为什么要从MeSH里筛选关键词？

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107650, encodeId=571c210e65007, content=submitted to journal 5天，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09758360980, createdName=ms3000000013472483, createdTime=Tue Dec 27 12:16:08 CST 2022, time=2022-12-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=895544, encodeId=5eea895544d8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一审时间比较久将近3个月，修改之后二十多天就接收了，在通讯作者确认发表相关信息的时候我有一个疑问，他让填写Co-author 我没明白这个指的是共同一作，还是指的所以文章贡献作者，请已经发表的同仁回复我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80cf2053027, createdName=傲娇的小马尾, createdTime=Thu Oct 29 23:45:50 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582558, encodeId=8dca58255853, content=with editor得多长时间啊？谢谢imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, beContent=imp_winner01072 2019-10-22 00:00:00 发表: 今天终于接收了，mark, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=880d2050661, createdName=NAOHOO, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231744, encodeId=c5871231e4429, content=with aditor一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Jul 11 10:44:33 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214032, encodeId=604b12140322d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：衰老 经验分享：一审64天；二审13天；三审6天；两个审稿人，非常专业，极其细节的问题均被关注到，不愧是老年医学的TOP👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Apr 25 07:37:54 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189869, encodeId=c5091189869a3, content=想问一下大家，投这个杂志要钱吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4092200580, createdName=120b32b6m98(暂无昵称), createdTime=Thu Feb 03 10:47:22 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189302, encodeId=d3fb11893026b, content=2022-1-26号提交 1-30还是submitted 给journal的状态我就看看自己哪天被处刑去年也是春节在家收到了无情的拒稿信 😭😭😭😭😭😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/3cbf68a0d92f4bbaacf574625e6155ce/fe60014b956f4e4c9543e1281f89b68c.jpg, createdBy=3b4e5080304, createdName=ms8406716658181247, createdTime=Sun Jan 30 14:46:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利 兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下 http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099440, encodeId=e6291099440b3, content=为什么要从MeSH里筛选关键词？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099439, encodeId=8c4e109943963, content=MeSH是什么东西？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 小动量

MeSH是什么东西？

33 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务